Induction of apoptosis in a neuroblastoma and hepatocyte coculture model

Journal of Surgical Research

Volumn 78, Issue 2, 1998, Pages 123-130

  Chen, Mike K ^a   Strande, Louise ^a   Kain, Michael ^a   Whalen, Thomas V ^a   Doolin, Edward J ^a  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

Apoptosis; Bcl 2; Chang hepatocytes; Neuroblastoma; Site specific metastasis; Tissue culture

Indexed keywords

PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER MODEL; COCULTURE; DNA DEGRADATION; HUMAN; HUMAN CELL; LIVER CELL CULTURE; NEUROBLASTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0344193111     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1998.5363     Document Type: Article

References (43)

1. Evans A. E., Baum E., Chard R. Do infants with stage IV-S neuroblastoma need treatments. Arch. Dis. Child. 56:1981;271.
2. McWilliams N. B. Stage IV-S neuroblastoma: Treatment controversy revisited. Med. Pediatr. Oncol. 14:1986;41.
3. Carlsen N. L. T. How frequent is spontaneous remission of neuroblastomas? Implications for screening. Br. J. Cancer. 61:1990;441.
4. Benard J. Genetic alterations associated with metastatic dissemination and chemoresistance in neuroblastoma. Eur. J. Cancer. 31A:1995;560.
5. Castle V. P., Heidelberger K. P., Bromemberg J., Ou X., Dole M., Nunez G. Expression of the apoptosis-suppressing protein bcl-2 in neuroblastoma is associated with unfavorable histology and N-myc amplification. Am. J. Pathol. 143:1993;1543.
6. Oue T., Fukuzawa M., Kusaflika T., Kohmoto Y., Imura K., Nagahara S., Okada A. In situ detection of DNA fragmentation and expression of bcl-2 in human neuroblastoma: Relation to apoptosis and spontaneous regression. J. Pediatr. Surg. 31:1996;251.
7. Hoehner J. C., Hedborg F., Wiklund H. J., Olsen L., Pahlman S. Cellular death in neuroblastoma: In situ correlation of apoptosis and bcl-2 expression. Int. J. Cancer. 62:1995;19.
8. Ikeda H., Hirato J., Akami M., Matsuyama S., Suuuki N., Takahashi A., Kuroiwa M. Bcl-2 oncoprotein expression and apoptosis in neuroblastoma. J. Pediatr. Surg. 30:1995;805.
9. Koizumi H., Wakisaka M., Nakada K., Takakuwa T., Fujioka T., Yamate N., Uchikoshi T. Demonstration of apoptosis in neuroblastoma and its relationship to tumor regression. Virchows Arch. 427:1995;167.
10. Lasorella A., Iavarone A., Israel M. A. Differentiation of neuroblastoma enhances Bcl-2 expression and induces alterations of apoptosis and drug resistance. Cancer Res. 55:1995;4711.
11. Ikeda H., Hirato J., Akami M., Suzuki N., Takahashi A., Kuroiwa M., Matsuyama S. Massive apoptosis detected by in situ DNA nick end labeling in neuroblastoma. Am. J. Surg. Pathol. 20:1996;649.
12. Imamura J., Bartram C. R., Berthold F., Harms D., Nakamura H., Koeffler H. P. Mutation of the p53 gene in neuroblastoma and its relationship with N-myc amplification. Cancer Res. 53:1993;4053.
13. Hosoi G., Hara J., Okamura T., Osugi Y., Ishihara S., Fukuzawa M., Okada A., Okada S., Tawa A. Low frequency of the p53 gene mutations in neuroblastoma. Cancer. 73:1994;3087.
14. Ellis R. E., Yuan J., Horvitz H. R. Mechanism and flinctions of cell death. Annu. Rev. Cell. Biol. 7:1991;663.
15. Fukuhara S., Rowley J. D., Variakojis D., Golomb H. M. Chromosome abnormalities in poorly differentiated lymphocytic lymphoma. Cancer Res. 39:1979;3119.
16. Tsujimoto Y., Finger L. R., Yunis J., Nowell P. C., Croce C. M. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science. 226:1984;1097.
17. Tsujimoto Y., Cossman J., Jaffe E., Croce C. Involvement of the bcl-2 gene in human follicular lymphoma. Science. 228:1985;1440.
18. Sentman C. L., Shutter J. R., Hockenbery D., Kanagawa O., Korsmeyer S. J. Bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell. 67:1991;879.
19. Strasser A., Harris A. W., Cory S. Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell. 67:1991;889.
20. McDonnell T. J., Deane N., Platt F. M., Nunez G., Jaeger U., Mckearn J. P., Korsmeyer S. J. Bcl-2 immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell. 57:1989;79.
21. Nunez G., Seto M., Seremetis S., Ferrero D., Grignani F., Korsmeyer S. J., Dalla-Favera R. Growth- and tumor-promoting effects of deregulated bcl-2 in human b-lymphoblastoid cells. Proc. Nail. Acad. Sci. USA. 86:1989;4589.
22. Tsujimoto Y. Overexpression of the human bcl-2 gene product results in growth enhancement of Epstein-Barr virus-immortalized B cells. Proc. Natl. Acad. Sci. USA. 86:1989;1958.
23. Lebrun D. P., Warnke R. A., Cleary M. L. Expression of bcl-2 in fetal tissues suggests a role in morphogenesis. Am. J. Pathol. 142:1993;743.
24. Lu Q. L., Poulsom R., Wong L., Hanby A. M. Bcl-2 expression in adult and embryonic non-haematopoietic tissues. J. Pathol. 169:1993;431.
25. Zhang K. Z., Westberg J. A., Holtta E., Andersson L. C. Bcl-2 regulates neural differentiation. Proc. Natl. Acad. Sci. USA. 93:1996;4504.
26. Hanada M., Krajewski S., Tanaka S., Cazals-Hatem D., Spengler B. A., Ross R. A., Biedler J. L., Reed J. C. Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells. Cancer Res. 53:1993;4978.
27. Guesdon J. L., Ternynck T., Avrameas S. The use of avidin-biotin interaction in immunoenzymatic techniques. J. Histochem. Cytochem. 27:1979;1131.
28. Gavrieli Y., Sherman Y., Ben-Sasson S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:1992;493.
29. Williams G. T. Programmed cell death: Apoptosis and oncogenesis. Cell. 65:1991;1097.
30. Vaux D. L., Cory S., Adams J. M. Bcl-2 oncogene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature. 335:1988;440.
31. Nunez G., London L., Hockenbery D., Alexander M., McKeam J., Korsmeyer S. J. Deregulated bcl-2 gene expression selective prolongs survival of growth factor-deprived hemopoietic cell lines. J. Immunol. 144:1990;3602.
32. Deng G., Podack E. R. Suppression of apoptosis in a cytotoxic T-cell line by interleukin 2-mediated gene transcription and deregulated expression of the proto-oncogene bcl-2. Proc. Natl. Acad. Sci. USA. 90:1993;2189.
33. 1. Cancer Res. 55:1995;2262.
34. Reed J. C. Bcl-2 and the regulation of programmed cell death. J. Cell Biol. 124:1994;1.
35. Reed J. C. Bcl-2: Prevention of apoptosis as a mechanism of drug resistance. Hematol. Oncol. Clin. North Am. 9:1995;451.
36. Miyashita T., Reed J. C. Bcl-2 gene transfer inceases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs. Cancer Res. 52:1992;5407.
37. Batistatou A., Merry D. E., Korsmeyer S. J., Green L. A. Expression of bcl-2 proto-oncogene rescues PC12 cells from death caused by withdrawal of trophic support. J. Neurosci. 13:1993;4422.
38. Allsopp T. E., Wyatt S., Paterson H. F., Davies A. M. The proto-oncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis. Cell. 73:1993;295.
39. Zhong L. T., Sarafian T., Kane D. J., Charles A. C., Mah S. P., Edwards R. H., Bredesen D. E. Bcl-2 inhibits death of central neural cells induced by multiple agents. Proc. Natl. Acad. Sci. USA. 90:1993;4533.
40. Hahn T., Or R., Bruchelt G., Malach Le., Karov Y., Lifshitz-Mercer B., Evron R., Barak Y. Control of neuroblastoma cell proliferation and differentiation by human bone marrow. Cancer. 77:1996;2614.
41. Scheil S., Ludecke G., Unsicker K. Interleukin-1β and interferon γ interact with fibroblast growth factors in the control of neuroblastoma cell proliferation and differentiation. Int. J. Neurosci. 12:1994;405.
42. Suzuki T., Bogenmann E., Shimada H., Stram D., Seeger R. C. Lack of high affinity nerve growth factor receptors in aggressive neuroblastomas. J. Natl. Cancer Inst. 85:1993;377.
43. Janet T., Ludecke G., Otten U., Unsicker K. Heterogeneity of human neuroblastoma cell lines in their proliferative responses to basic FGF, NGF, and EGF: Correlation with expression of growth factors and growth factor receptors. J. Neurosci. Res. 40:1995;707.